Companies › QCLS

Q/C TECHNOLOGIES INC (QCLS)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001321834 · EDGAR filings · Updated 2026-07-02

Q/C TECHNOLOGIES INC (QCLS) has reported institutional ownership of 8.0%, with 18 institutional managers holding positions valued at $2.16M per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings.

Latest updates

• 2026-07-02 — Current report (8-K) filed
• 2026-05-15 — Quarterly report (10-Q) filed
• 2026-05-14 — Insider transaction reported (Form 4)
• 2026-04-29 — 10-K/A filed
• 2026-04-15 — Insider transaction reported (Form 4)
• 2026-04-15 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, Q/C TECHNOLOGIES INC has 18 institutional holders and institutional ownership of 8.0%.

Insider activity

Insiders reported 13 transactions (0 buys, 0 sells) across 7 reporting insiders, with a net reported value of $0.

Data flags from SEC filings

Related companies

MIRA PHARMACEUTICALS INC COM (MIRA) · IMPACT BIOMEDICAL INC (IBO) · Outlook Therapeutics Inc (OTLK) · SYNERGY CHC CORP (SNYR) · VIVOS THERAPEUTICS INC (VVOS) · Reviva Pharmaceuticals Holdings Inc (RVPH)